Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5955
    +0.0018 (+0.30%)
     
  • NZD/EUR

    0.5555
    +0.0010 (+0.17%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    83.02
    +0.21 (+0.25%)
     
  • GOLD

    2,334.40
    -4.00 (-0.17%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    0.00 (0.00%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,276.92
    +75.65 (+0.44%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • NZD/JPY

    92.6840
    +0.5690 (+0.62%)
     

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Bavarian Nordic A/S
Bavarian Nordic A/S

COPENHAGEN, Denmark, December 8, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Paul Chaplin

2.

Reason for the notification

a)

Position/status

President and Chief Executive Officer of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument


Identification code

Warrants


DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

88,325

d)

Aggregated information

  • Aggregated volume

  • Price



88,325
DKK 0.00

e)

Date of the transaction

2022-12-08

f)

Place of the transaction

Outside a trading venue


1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Henrik Juuel

2.

Reason for the notification

a)

Position/status

Executive Vice President and Chief Financial Officer of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument


Identification code

Warrants


DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

38,162

d)

Aggregated information

  • Aggregated volume

  • Price



38,162
DKK 0.00

e)

Date of the transaction

2022-12-08

f)

Place of the transaction

Outside a trading venue


1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jean-Christophe May

2.

Reason for the notification

a)

Position/status

Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument


Identification code

Warrants


DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

34,263

d)

Aggregated information

  • Aggregated volume

  • Price



34,263
DKK 0.00

e)

Date of the transaction

2022-12-08

f)

Place of the transaction

Outside a trading venue


1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Laurence De Moerlooze

2.

Reason for the notification

a)

Position/status

Executive Vice President and Chief Medical Officer of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument


Identification code

Warrants


DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

32,934

d)

Aggregated information

  • Aggregated volume

  • Price



32,934
DKK 0.00

e)

Date of the transaction

2022-12-08

f)

Place of the transaction

Outside a trading venue


1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Anu Helena Kerns

2.

Reason for the notification

a)

Position/status

Executive Vice President People & Organization of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument


Identification code

Warrants


DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

22,902

d)

Aggregated information

  • Aggregated volume

  • Price



22,902
DKK 0.00

e)

Date of the transaction

2022-12-08

f)

Place of the transaction

Outside a trading venue


1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Russell Thirsk

2.

Reason for the notification

a)

Position/status

Executive Vice President and Chief Operating Officer of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument


Identification code

Warrants


DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

32,201

d)

Aggregated information

  • Aggregated volume

  • Price



32,201
DKK 0.00

e)

Date of the transaction

2022-12-08

f)

Place of the transaction

Outside a trading venue

About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Government of a non-replicating smallpox vaccine, which has been approved by the FDA, also for the protection against mpox (monkeypox). The vaccine is also approved in Canada and Europe. Our commercial product portfolio furthermore contains market-leading vaccines against rabies and tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccine. For more information visit www.bavarian-nordic.com.

ADVERTISEMENT

Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600

Company Announcement no. 44 / 2022

Attachment